+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
ID05593055

Study Comparing Eplerenone and Chlorthalidone Treatments on Heart Function and Blood Flow in Adults with High Blood Pressure and Enlarged Heart

Led by Brigham and Women's Hospital · Updated on 2026-04-06

75

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how two different treatments affect heart function in adults with high blood pressure hypertension and thickened heart muscle left ventricular hypertrophy or LVH. This study compares a mineralocorticoid receptor MR antagonist called eplerenone with a thiazide-like diuretic called chlorthalidone. The goal is to see which treatment better improves the small blood vessel function in the heart and the hearts efficiency, potentially leading to improvements in heart structure and function. Participants with hypertension and LVH, who are currently taking ACE inhibitors or angiotensin receptor blockers, will switch to enalapril and stop other blood pressure medicines before starting the study treatments. After a pre-treatment assessment, they will be randomly assigned to receive either eplerenone or chlorthalidone with potassium supplements. The doses will increase after two weeks, and amlodipine may be added later if needed to reach a target blood pressure under 13585 mmHg. Treatment will last for 9 months. During the study, participants will undergo cardiac PET scans to measure coronary microvascular function and cardiac efficiency. Echocardiograms will assess heart function and structure changes. Other tests will measure heart oxygen use, markers of heart injury, and hormone system activity. The main outcomes focus on changes in myocardial flow reserve and myocardial external efficiency after 9 months. Safety and effectiveness will be monitored throughout the study period, which runs until the end of 2027.

CONDITIONS

Brief Title

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Research Team

G

Gail K Adler, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here